For the first time in the program's history, the standard Medicare Part B monthly premium has crossed the $200 mark. In 2026, beneficiaries pay $203.90 per month — up from $185.00 in 2025, an increase of nearly $19 per month or about $227 over the course of a year.
For the roughly 68 million Americans enrolled in Medicare, this milestone raises a straightforward question: why do premiums keep climbing, and what can you do about it?
This article breaks down the forces behind the 2026 increase, puts it in historical context, and outlines practical steps you can take to reduce what you pay.
How Part B Premiums Are Set
Before examining what drove the increase, it helps to understand where your premium dollars go. Medicare Part B covers outpatient care — doctor visits, lab tests, durable medical equipment, ambulance services, mental health care, and certain drugs administered in clinical settings (such as infusions and injections).
Each fall, the Centers for Medicare & Medicaid Services (CMS) announces the following year's Part B premium based on projected spending. By law, premiums must cover approximately 25 percent of expected Part B program costs. The remaining 75 percent comes from general federal revenue. When projected spending rises, premiums follow.
The Part B annual deductible also increased for 2026, rising to $257 before Medicare begins paying its share of covered services.
What Pushed Premiums Past $200
No single factor explains the increase. Rather, several trends converged to push the standard premium to $203.90.
Rising Healthcare Prices and Utilization
The most fundamental driver is the same one that has been pushing premiums upward for decades: healthcare costs continue to grow faster than general inflation. Hospital outpatient services, physician-administered drugs, diagnostic imaging, and laboratory tests have all seen price increases. At the same time, an aging population is using more services. CMS cited "projected price changes and assumed utilization increases consistent with historical experience" as the primary reasons for the 2026 premium and deductible hike.
Medicare Advantage Overpayments
A growing body of evidence points to overpayments to Medicare Advantage (MA) plans as a significant — and avoidable — contributor to rising Part B premiums. A March 2026 issue brief from the Joint Economic Committee (JEC) of the U.S. Congress found that in 2025, the federal government paid MA insurers an estimated $76 billion to $84 billion more than it would have cost to cover the same beneficiaries under Original Medicare.
Because Part B premiums are calculated based on total program spending — including payments to MA plans — these overpayments flow directly into the premium that every beneficiary pays, regardless of whether they are enrolled in Medicare Advantage or Original Medicare. The JEC estimated that MA overpayments added roughly $212 per enrollee in 2025, totaling $13.4 billion in inflated premiums. Since 2016, cumulative overpayments have added an estimated $82 billion to Part B premiums.
Original Medicare beneficiaries bore approximately $6 billion of these costs in 2025 alone, even though they chose not to enroll in MA plans. This dynamic has prompted CMS to propose reforms that would gradually align MA payment rates more closely with Original Medicare costs.
High-Cost Specialty Drugs Under Part B
Part B covers drugs that are administered in clinical settings — infusions, injections, and certain oral medications tied to covered treatments. Several categories of high-cost Part B drugs have contributed to spending growth:
Alzheimer's disease treatments. Medicare now covers newer Alzheimer's drugs such as Leqembi (lecanemab) and Kisunla (donanemab) under Part B. These monoclonal antibody infusions carry annual costs of approximately $26,500 to $32,000 per patient. As more beneficiaries gain access to these treatments, the aggregate spending impact on Part B grows. The 2022 premium spike of $21.60 per month — the largest single-year jump in Medicare history at that time — was driven in large part by the anticipated cost of Aduhelm, a previous Alzheimer's drug. Although Aduhelm was ultimately withdrawn, the pattern established a precedent: costly new drugs covered under Part B can move premiums meaningfully.
GLP-1 receptor agonists. While most GLP-1 medications like Ozempic and Wegovy are covered under Part D (prescription drug plans), their broader impact on healthcare spending reverberates across Medicare. CMS launched the Medicare GLP-1 Bridge demonstration in mid-2026 to begin covering certain GLP-1 drugs for weight management, and the Congressional Budget Office has projected that broader Medicare coverage of anti-obesity medications could carry substantial costs. As these drugs move closer to standard coverage, the budgetary pressure on the entire Medicare program intensifies.
Skin substitutes and wound care products. CMS noted that without administrative action to address "unprecedented spending on skin substitutes," the 2026 Part B premium increase would have been approximately $11 more per month. Regulatory changes finalized in the 2026 Physician Fee Schedule are expected to reduce skin substitute spending by 90 percent, which helped contain — but not eliminate — premium growth.
General Healthcare Inflation
Beyond specific drug categories, the broader healthcare economy experienced inflationary pressures through 2024 and 2025. Hospital labor costs, supply chain disruptions, and facility expansion all contributed to higher prices for outpatient services. These systemwide cost increases feed directly into Part B spending projections and, by extension, into the premium calculation.
A Decade of Premium Growth
The 2026 premium did not appear in a vacuum. Looking at the historical trajectory shows how steadily Part B costs have climbed:
| Year | Monthly Premium | Year-Over-Year Change | |------|----------------|-----------------------| | 2016 | $121.80 | — | | 2017 | $134.00 | +$12.20 | | 2018 | $134.00 | $0.00 | | 2019 | $135.50 | +$1.50 | | 2020 | $144.60 | +$9.10 | | 2021 | $148.50 | +$3.90 | | 2022 | $170.10 | +$21.60 | | 2023 | $164.90 | -$5.20 | | 2024 | $174.70 | +$9.80 | | 2025 | $185.00 | +$10.30 | | 2026 | $203.90 | +$18.90 |
Over this decade, the standard premium has increased by roughly 67 percent — from $121.80 to $203.90. By comparison, the cumulative consumer price inflation over the same period was considerably lower. Research from AARP's Public Policy Institute has shown that Part B premiums grew at an average annual rate of 5.5 percent from 2005 to 2024, while Social Security cost-of-living adjustments averaged just 2.6 percent. This gap means that for many beneficiaries, premium increases eat into — or even exceed — their annual Social Security raise.
The single decrease in 2023 occurred after the anticipated costs of Aduhelm failed to materialize, and CMS recalculated spending projections downward. That adjustment was temporary, and premiums resumed their upward trajectory in 2024.
IRMAA: When $203.90 Is Just the Starting Point
Beneficiaries with higher incomes pay more than the standard premium through the Income-Related Monthly Adjustment Amount, or IRMAA. These surcharges are based on your modified adjusted gross income (MAGI) from two years prior — for 2026 premiums, that means your 2024 tax return.
Here is what Part B premiums look like across IRMAA brackets for 2026:
| Individual MAGI | Joint MAGI | Monthly Premium | |-----------------|------------|-----------------| | $106,000 or less | $212,000 or less | $203.90 | | $106,001 – $133,000 | $212,001 – $266,000 | $284.10 | | $133,001 – $167,000 | $266,001 – $334,000 | $404.80 | | $167,001 – $200,000 | $334,001 – $400,000 | $525.50 | | $200,001 – $499,999 | $400,001 – $749,999 | $646.20 | | $500,000 or more | $750,000 or more | $666.90 |
At the highest bracket, a beneficiary pays $666.90 per month — more than three times the standard premium. IRMAA surcharges also apply to Part D prescription drug premiums, compounding the cost for higher-income enrollees.
It is worth noting that a one-time income event — such as selling a home, converting a traditional IRA to a Roth IRA, or receiving a large capital gain — can temporarily push you into a higher IRMAA bracket, even if your ongoing income is well below the threshold.
What Beneficiaries Can Do
While you cannot change the standard premium, there are several concrete steps that may reduce what you actually pay.
Check Your Eligibility for Medicare Savings Programs
If your income and assets are limited, your state may help pay some or all of your Medicare costs through Medicare Savings Programs (MSPs). There are four levels:
- Qualified Medicare Beneficiary (QMB): Covers Part A and Part B premiums, deductibles, and coinsurance. Available to individuals with income below 100 percent of the federal poverty level.
- Specified Low-Income Medicare Beneficiary (SLMB): Covers your Part B premium. Available to individuals with income between 100 and 120 percent of the federal poverty level.
- Qualifying Individual (QI): Covers your Part B premium. Available to individuals with income between 120 and 135 percent of the federal poverty level.
- Qualified Disabled and Working Individuals (QDWI): Covers Part A premiums for certain working individuals with disabilities.
Income and asset limits vary by state, and many states set thresholds higher than the federal minimums. You apply through your state Medicaid office. Enrolling in an MSP also automatically qualifies you for Extra Help with Part D prescription drug costs.
Appeal Your IRMAA Surcharge
If you are paying an IRMAA surcharge based on income from two years ago, but your financial circumstances have since changed due to a life-changing event, you may be able to request a reduction. Qualifying events include:
- Retirement or reduced work hours
- Marriage or divorce
- Death of a spouse
- Loss of income-producing property
- Loss of pension income
To request a reconsideration, complete Form SSA-44 and submit it to your local Social Security office. For a step-by-step guide, see our article on how to appeal your IRMAA surcharge. You will need to provide documentation of the event and your current income. You can also call Social Security at 1-800-772-1213 to begin the process.
Deduct Part B Premiums on Your Taxes
If you are self-employed, you may be able to deduct Medicare Part B premiums (including IRMAA surcharges) as a business expense. Even if you are not self-employed, you can include Part B premiums in your itemized medical expenses — though medical expenses are only deductible to the extent they exceed 7.5 percent of your adjusted gross income. Consult a tax professional to determine whether this applies to your situation.
Manage Your MAGI Proactively
Since IRMAA is based on income from two years prior, forward planning can help. If you are approaching retirement, consider the timing of IRA conversions, asset sales, or pension distributions to avoid unnecessarily spiking your MAGI in the years that will be used for IRMAA calculations. A financial advisor familiar with Medicare planning can help you develop a multi-year strategy.
Review Your Coverage Annually
Even though Part B premiums are set by CMS and cannot be negotiated, you can influence your total Medicare spending by reviewing your supplemental coverage each year. If you have a Medigap policy, compare plans during available enrollment opportunities. If you are in a Medicare Advantage plan, use the Medicare Plan Finder at Medicare.gov to compare costs, coverage, and provider networks during Open Enrollment each fall.
Will Premiums Keep Rising?
The short answer: most projections say yes, though the pace is uncertain.
The 2025 Medicare Trustees Report projected that Part B premiums could approach $350 per month by 2034, representing an increase of roughly 70 percent from 2026 levels. The JEC report estimated that per-person premiums could nearly double from approximately $2,440 annually today to about $5,000 by 2035.
Several factors will influence the trajectory:
- Medicare Advantage payment reform. CMS has proposed reducing MA overpayments, which could slow premium growth if implemented. However, the insurance industry has strongly opposed these changes, and the political path forward remains uncertain.
- Drug pricing negotiations. The Inflation Reduction Act's drug price negotiation program has already produced lower prices for 10 high-cost medications, with 15 more scheduled for 2027. If the program expands and is sustained, it could meaningfully reduce Part B drug spending over time.
- New therapies and technologies. Continued approval of expensive specialty drugs — particularly in oncology, neurology, and metabolic disease — will create upward pressure on spending. Each new breakthrough treatment that Medicare covers contributes to the spending base from which premiums are calculated.
- Demographics. Approximately 10,000 Americans turn 65 every day. As the Medicare-eligible population grows, total program costs rise even if per-person spending remains flat.
The Bottom Line
The $203.90 monthly premium is a milestone, but it reflects trends that have been building for years. Healthcare prices, utilization growth, Medicare Advantage overpayments, costly new therapies, and an expanding beneficiary population have all played a role.
Understanding what drives your premiums is the first step toward managing them. Whether that means applying for a Medicare Savings Program, appealing an IRMAA surcharge, or planning your income strategy to minimize future surcharges, there are meaningful actions available to most beneficiaries.
For personalized assistance, contact 1-800-MEDICARE (1-800-633-4227), visit Medicare.gov, or reach out to your State Health Insurance Assistance Program (SHIP) for free, unbiased counseling.